MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort

K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

Meeting: 2024 International Congress

Abstract Number: 480

Keywords: Parkinson’s

Category: Epidemiology

Objective: To compare the distribution of Parkinson’s disease (PD) risk markers and comprehensive risk scores in an online-cohort recruited with open invitations through a media campaign versus a ‘true’ population-based sample.

Background: Validations of risk scores for prodromal PD yielded variable performances depending on the cohort in which they were applied. Different cohort types and recruitment designs are likely to influence distribution of risk markers within risk scores and performance of the scores.

Method: Analysis was performed in the Tyrol cohort of the Healthy Brain Ageing (HeBA) study, a European multi-centre study on the prevalence and predictivity of risk factors for PD; and the Bruneck Study cohort, a prospective study on neurological and cardiovascular diseases representative of the general elderly population. Data in the HeBA cohort has been collected starting from April 2022 via online-questionnaires and subsequent remote smell testing (n=1275). For the Bruneck Study sample data from past in-person follow-up examinations were used (n=540), recruited initially through invitation from the official population register as an age- and sex-stratified random sample. For the present analysis we focused on simple and established risk factors (family history, olfaction, probable REM-sleep behaviour disorder [RBD], depression, constipation and orthostatic hypotension) and applied the updated MDS research criteria for prodromal PD.

Results: Participants of the HeBA cohort were younger and had a female preponderance compared with the Bruneck cohort (median age 61 [25th–75th percentile: 56–67] vs. 67 [61–76] years, p<0.001; % females 59% vs. 54%, p=0.029). Positive family history (16.1% vs. 7.6%, p<0.001), symptoms of RBD (21.1% vs. 7.7%, p<0.001), constipation (12.4% vs. 9.3%, p=0.055), and orthostatic hypotension (21.0% vs. 9.6%, p<0.001) were more frequent in the HeBA cohort, while symptoms of depression (42.4% vs. 29.8%, p<0.001) were more frequent in the Bruneck cohort. Equal distribution was found for hyposmia (40.0 vs. 39.6%, p=0.906). Probabilities for prodromal PD were higher in the Bruneck cohort (2.4% [0.5–10.7%] vs. 1.0% [0.3–3.1%], p<0.001).

Conclusion: Distributions of risk factors and risk scores differ in the compared cohorts, probably owing to differences in cohort characteristics including age and recruitment strategies.

To cite this abstract in AMA style:

K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht. Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/cohort-effects-on-risk-scores-and-risk-markers-for-parkinsons-disease-comparison-of-an-online-recruited-versus-population-based-cohort/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cohort-effects-on-risk-scores-and-risk-markers-for-parkinsons-disease-comparison-of-an-online-recruited-versus-population-based-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley